Dr Collins is a fellow of the American Board of Forensic Toxicology and holds certification as a high-complexity laboratory director (HCLD) from the American Board of Bioanalysis. She earned her PhD from Northwestern University and a Public Health Certificate in Core Concepts (PHCert-CC) from the University of Minnesota. She is currently a laboratory director at MedTox Laboratories, a member of the Labcorp Specialty Testing Group. She joined MedTox in 1994.

Dr. Otvos received a Ph.D. in comparative biochemistry from the University of California-Berkeley and postdoctoral training in molecular biophysics at Yale University.  He spent the following 20 years in academia, first on the chemistry faculty of the University of Wisconsin-Milwaukee and then as Professor of Biochemistry at North Carolina State University during which time he developed new technology for measuring lipoprotein particles using nuclear magnetic resonance (NMR) spectroscopy. He then founded LipoScience, Inc.

Dr Engler is a diplomate of the American Board of Medical and Public Health Microbiology. He earned his PhD in medical microbiology and immunology from The Ohio State University. He completed postdoctoral fellowship training in medical and public health microbiology at the Mt. Sinai Medical Center in New York.

Dr Vall is a board-certified clinical laboratory scientist (CLS) and holds a Qualification in Cytometry (QCYM) certification from the American Society for Clinical Pathology. He received his doctorate at the National University of Rosario, Argentina.

Dr Dong is board certified in anatomic pathology and hematopathology. He earned his medical degree from Beijing Medical University and his PhD in molecular cell biology from the Albert Einstein College of Medicine. He was a postdoctoral research fellow at the Dana Farber Cancer Institute. Dr Dong completed his pathology residency at Massachusetts General Hospital followed by a Vickery fellowship in surgical pathology and a James Homer fellowship in hematopathology.